Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Jul 29, 2016 · 10-Q · 29 days after period end · 0001213900-16-015402
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | -$6.62M | -$7.46M | $3.52M | -$2.78M |
| EPS Diluted | -$0.15 | -$0.20 | $0.10 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Jul 29, 2016 · 29 d after period end
